在退行性Perceval生物假体中通过导管置换大动脉:32例病例的临床和技术方面
Giovanni Concistrè1, Tommaso Gasbarri1, Marcello Ravani2
1Department of Adult Cardiac Surgery, G. Pasquinucci Heart Hospital, Fondazione CNR-G. Monasterio, 54100 Massa, Italy.
Journal of clinical medicine
|October 14, 2023
概括
内透管大动脉置换 (VIV-TAVR) 为退化无的Perceval大动脉生物假体提供了安全有效的解决方案. 这种方法在需要重新干预的患者中显示出出色的临床结果和血液动力学性能.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 生物材料科学 生物材料科学
背景情况:
- 像Perceval一样,无纹的大动脉生物假体在最小侵入性大动脉置换中提供了好处.
- 这些门的退化需要重新干预,而门内透导管大动脉替换 (VIV-TAVR) 成为一个可行的选择.
- 这项研究评估了VIV-TAVR在患有变性Perceval生物假体的患者的结果.
研究的目的:
- 在患有退化的Perceval无大动脉生物假体的患者中,评估内透导管大动脉置换 (VIV-TAVR) 的临床结果和技术方面.
- 评估VIV-TAVR作为治疗失败的无动脉的治疗策略的安全性和有效性.
主要方法:
- 在2011年3月至2023年3月期间接受Perceval生物假体植入的1310名患者的回顾性分析.
- 在植入后平均6.4年的时间内,鉴定了32名因严重生物假体退化而接受VIV-TAVR的患者.
- 数据收集包括程序细节,并发症,住院和随访临床和血液动力学参数.
主要成果:
- 在32名患者中成功进行了VIV-TAVR,其中94%是通过输方法进行的.
- 血管并发症很少 (6%),平均住院时间为4.6天.
- 平均随访时间为16.7个月,生存率为100%,平均跨膜压力梯度为18.7mmHg.
结论:
- 内透管大动脉置换 (VIV-TAVR) 是对退化的Perceval无大动脉生物假体的安全有效治疗方法.
- 该程序与良好的临床结果和出色的血液动力学性能有关.
- 这种单一中心的经验支持VIV-TAVR作为管理失败的无动脉的宝贵选择.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Valve Prolapse II: Assessment and Management
20
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
20
Aortic Regurgitation I: Introduction
10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Valve Prolapse I: Introduction
21
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
21
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
22
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22


